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Abstract
Background: Insomnia is a common complaint among individuals with migraine. The close association between
insomnia and migraine has been reported in clinic-based and population-based studies. Probable migraine (PM) is a
migrainous headache which fulfills all but one criterion in the migraine diagnostic criteria. However, an association
between insomnia and PM has rarely been reported. This study is to investigate the association between insomnia
and PM in comparison with migraine using data from the Korean Headache-Sleep Study.
Methods: The Korean Headache-Sleep Study is a nation-wide cross-sectional survey for all Korean adults aged
19–69 years. The survey was performed via face-to-face interview using a questionnaire on sleep and headache.
If an individual’s Insomnia Severity Index score was ≥15.5, she/he was diagnosed as having insomnia.
Results: Of 2695 participants, the prevalence of migraine, PM and insomnia was 5.3, 14.1 and 3.6 %, respectively.
The prevalence of insomnia among subjects with PM was not significantly different compared to those with
migraine (8.2 % vs. 9.1 %, p = 0.860). However, insomnia prevalence in subjects with PM was significantly higher
than in non-headache controls (8.2 % vs. 1.8 %, p < 0.001). Insomnia Severity Index score was significantly higher in
subjects with migraine compared to those with PM (6.8 ± 5.8 vs. 5.5 ± 5.8, p = 0.012). Headache frequency and
Headache Impact Test-6 score were significantly higher in subjects with migraine and PM with insomnia compared
to those without insomnia. Multivariable linear analyses showed that anxiety, depression, headache frequency and
headache intensity were independent variables for contributing the ISI score among subjects with PM.
Conclusions: The prevalence of insomnia among subjects with PM was not significantly different compared to
those with migraine. Anxiety, depression, headache frequency and headache intensity were related with ISI score in
subjects with PM.
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Background
Insomnia and migraine are common complaints among
the general population, affecting 10–30 % and 5–15 % of
the general population, respectively [1–3]. Both individ-
uals with insomnia and individuals with migraine experi-
ence a limitation of functions and a decrease in quality of
life(QOL) due to their symptoms [4–6]. Recent studies
have revealed that both conditions imposed a huge
amount of personal and social burdens [4, 7].
A close association between insomnia and migraine
has been described in previous population-based studies
[8–16]. In cross-sectional studies, individuals with mi-
graine had an increased risk of having insomnia [odds
ratio (OR) = 1.4–2.6] compared to non-migraineurs and
individuals with insomnia had a higher risk of having
migraine (OR = 1.5–1.7) compared to individuals with-
out insomnia [8, 11–16]. Longitudinal studies also
showed an increase risk [relative risk (RR) = 1.7] for
having insomnia among individuals with migraine after
11 years [9]. The association was stronger for those with
high frequency migraine. Conversely, individuals with
insomnia showed an increased risk of having migraine at
11-year follow-up (RR = 1.7) [10].
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Probable migraine (PM) is a migrainous headache
fulfilling all but one of the criteria for migraine [17].
Probable migraine was reported to be a common sub-
type of migraine, with a 1-year prevalence rate ranging
from 4.3 to 14.6 % according to the previous population-
based studies [18–20]. PM is a common headache type
for visiting doctors in neurology department [21].
Individuals with PM often experienced headache-related
disability and decreased QOL like migraine [18, 19].
Therefore, PM is an important type of headache in
clinical practice.
Although insomnia appears to be closely associated
with migraine, the association between insomnia and
PM has rarely been reported. The Korean Headache-
Sleep Study (KHSS) was a population-based survey
regarding headache type and sleep and provided an op-
portunity to evaluate the association between insomnia
and PM. In the present study, we 1) described the preva-
lence of insomnia, migraine and PM across a general
population-based sample; 2) compared the prevalence of
insomnia between migraine and PM; and 3) assessed the
impact of insomnia in clinical characteristics of migraine
and PM using the data from KHSS.
Methods
Survey
We used data from the KHSS in the present study. The
KHSS was a nationwide, cross-sectional survey regarding
headache types, symptoms of anxiety and depression,
and sleep status among the adult population aged 19–69
years. The study design and methods of KHSS have been
previously described in detail [22]. Briefly, we used a
2-stage clustered random sampling method for all Korean
territories except Jeju-do, proportional to the population
distribution. All interviewers were employees of Gallup
Korea and had previously experience with social survey
interviewing. The survey was conducted by door-to-door
visits and face-to-face interviews from November 2011 to
January 2012. The study was approved by the institutional
review board/ethics committee of Hallym University
Sacred Heart Hospital and was performed in accordance
with the ethical standards laid out in the 1964 Declaration
of Helsinki and its subsequent amendments [23].
Informed consent was obtained from all participants
before each interview.
Assessment of migraine and PM
Diagnoses of migraine and PM were based on criteria A
to D for migraine without aura (code 1.1) in the second
edition of the International Classification of Headache
Disorders (ICHD-2) [A, at least five attacks; B, attack
duration of 4–72 h; C, any 2 of the 4 typical headache
characteristics (i.e., unilateral location, pulsating quality,
moderate-to-severe pain intensity, and aggravation by or
caused by routine physical activity); and D, attacks
associated with at least one of the following: nausea,
vomiting, or both photophobia and phonophobia] [17].
Subjects who met all of these criteria were considered to
have migraine, whereas subjects who met all criteria
except one were considered to have PM. Cases with
headaches that met the criteria for both PM and
tension-type headaches did not receive a PM diagnosis,
as per ICHD-2. Because migraine and PM with aura
(codes 1.2.1 and 1.6.2, respectively) are difficult to
document using the questionnaire method, we did not
evaluate aura [24]. Accordingly, these conditions were
classified as migraine and PM in the present study.
Assessment of insomnia
We used the Insomnia Severity Index (ISI) to diagnose
and classify insomnia among subjects. The ISI is a brief
self-reported questionnaire that measures the patient’s
perception of insomnia severity [25]. The ISI is
composed of 7 items that evaluate various aspects of
insomnia symptoms. Each ISI item was rated on a scale
of 0–4. The total ISI score were divided into 4 catego-
ries: 0–7, no clinically significant insomnia; 8–14,
subthreshold insomnia; 15–21: moderate insomnia; and
22–28: severe insomnia. If a participant’s ISI score was
15.5 or more, she/he was diagnosed as having insomnia.
The Korean version of ISI was previously validated with
good sensitivity and specificity and showed a 15.5 cut-off
score for discriminating patients with insomnia [26].
Assessment of anxiety and depression
We used the Goldberg Anxiety Scale (GAS) to diagnose
anxiety among subjects. This scale comprises four
screening items and five supplementary items [27, 28].
Subjects who answered positively for two or more
screening items and five or more of all scale items were
classified as having anxiety. The Korean version of the
scale has an 82.0 % sensitivity and 94.4 % specificity for
diagnosing anxiety [28].
The Patient Health Questionnaire-9(PHQ-9) was used
to diagnose depression [29]. Subjects who had scores of
10 or more on this measure were considered to have
depression. The Korean version of PHQ-9 has an 81.1 %
sensitivity and 89.9 % specificity [30].
Analyses
The Kolmogorov–Smirnov test was used to evaluate the
normality of the distribution; after the normality was
confirmed, we utilized Student’s t-test and Chi-square
test for comparison of prevalence rates where appropriate.
If the normality of the distribution was not confirmed, we
used Mann–Whitney U test. Multiple linear regression
analysis with stepwise selection was used to evaluate
contributing factors for ISI score among patients with
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PM. A significance level of p < 0.05 was set for all analyses.
Statistical analyses were performed with the Statistical
Package for the Social Sciences 22.0 (SPSS 22.0; IBM,
Armonk, NY, USA).
As with most survey sampling designs, there were miss-
ing data (resulting from non-response) for several vari-
ables. All of the reported results are based on the available
data; as such, the total numbers of some variables diverge
from 2695 because of missing data for that particular
variable. Imputation techniques were not used because we
wanted to minimize non-response effects [31].
Results
Survey
Interviewers approached 7430 individuals. Although
three thousand one hundred and fourteen agreed to par-
ticipate in the survey (rejection rate 58.1 %), 419 individ-
uals withdrew from participation in the interview. Overall,
2695 subjects completed the survey (cooperation rate
36.3 %; Fig. 1). We found no significant differences in the
distributions of age, gender, size of residential area, and
educational level from those of the general population of
Korea (Table 1).
Prevalence of migraine, PM and insomnia
Of the 2695 subjects, 143 (5.3 %) were classified as having
migraine and 379 (14.1 %) were classified as having PM
during the previous year. Among participants, 333
(12.4 %) had subthreshold insomnia, 83 (3.1 %) had
moderate insomnia and 26 (1.0 %) had severe insomnia.
Ninety six (3.6 %) reported ≥ 15.5 ISI score and were clas-
sified as having insomnia (Table 1).
Prevalence and severity of insomnia among subjects with
migraine and PM
Thirteen (9.1 %) subjects with migraine and 31 (8.2 %)
subjects with PM were diagnosed as having insomnia.
The prevalence of insomnia among subjects with PM
was not significantly different compared to those with mi-
graine (p = 0.860). Compared to non-headache controls
(1.8 %), the prevalence of insomnia among subjects with
migraine [OR = 5.6, 95 % confidence interval (CI) =
2.8–11.2, p < 0.001] and PM (OR = 5.0, 95 % CI = 2.9–
8.5, p < 0.001) was significantly higher. Subjects with
migraine had higher ISI score compared to subjects
with PM (6.8 ± 5.8 vs. 5.5 ± 5.8, p = 0.012). The pro-
portion of severe insomnia (2.8 % vs. 2.4 %, p = 0.782)
and moderate insomnia (6.3 % vs. 7.1 %, p = 0.739)
was not significantly different between migraine and
PM. However, the proportion of subclinical insomnia
was higher among subjects with migraine compared
to those with PM (28.7 % vs. 16.4 %, p = 0.002)
(Fig. 2).
Demographic and clinical characteristics of subjects with
migraine and PM according to the presence of insomnia
Subjects with migraine and PM who had insomnia
showed significantly higher GAS score and PHQ-9 score
compared to those without insomnia. However, sociode-
mographic variables such as age, proportion of gender,
size of residential and education level were not different
according to the presence of insomnia (Table 2).
Headache characteristics of migraine and PM according
to the presence of insomnia
The median and 25–75 % interquantile range values of
the headache frequency, Visual Analog Scale (VAS) score
for headache intensity and Headache Impact Test-6
(HIT-6) score were shown in Table 3. Subjects with mi-
graine and PM who had insomnia showed significantly
higher headache frequencies per month [migraine: 4.0,
(2.0–11.0) vs. 1.0 (0.3–4.0), p = 0.004; PM: 2.0 (0.4–4.0)
vs. 1.0 (0.3–2.0), p = 0.004] and HIT-6 scores [migraine:
65.0 (59.5–71.5) vs. 52.0 (47.0–60.0), p < 0.001; PM: 54.0
(48.0–62.0) vs. 45.5 (42.0–52.0), p < 0.001] compared to
those without insomnia. Subjects with PM who had
insomnia showed significantly higher VAS score for
headache intensity [PM: 6.0 (5.0–7.0) vs. 5.0 (4.0–6.0), p <
0.001) compared to those without insomnia, but subjects
with migraine who had insomnia [migraine: 7.0 (5.5–8.5)
vs. 6.0 (5.0–7.0), p = 0.076] did not show significantly dif-
ferent VAS score compared to those without insomnia.
Multiple linear regression analyses for contributing
factors for ISI score in subjects with PM
We performed the multiple linear regression analyses of
clinical variables including sociodemographic variables
Fig. 1 Flow chart depicting the participation of subjects in the Korean
Headache-Sleep Study
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(age, gender, size of residential area, educational level),
GAS score, PHQ-9 score, headache frequency and VAS
score to evaluate the contributing factors for ISI score
(Table 4). The strongest contributing factor was
PHQ-9 score (β = 0.530, p < 0.001), followed by GAS
score (β = 0.268, p < 0.001), headache frequency (β = 0.119,
p < 0.001) and VAS score (β = 0.076, p = 0.026) for head-
ache intensity.
Discussion
The main findings in the present study are as follows: 1)
The prevalence of migraine, PM and insomnia in the
Korea population was 5.3, 14.1 and 3.6 %, respectively;
2) The prevalence of insomnia among subjects with PM
(8.2 %) was not significantly different compared to that
among subjects with migraine (9.1 %); 3) Headache fre-
quency and HIT-6 score of subjects were higher among
migraine and PM subjects with insomnia compared to
those without insomnia.
The 1-year prevalence of migraine (5.3 %) in the
present study was lower than in previous studies from
European (10–25 %) and North American (9–16 %)
countries [1]. However, the 1-year prevalence of
migraine in Asian countries was 4.7 to 9.1 %, which were
lower compared to that in European and North American
studies [32]. The migraine prevalence in our study was
similar to previous studies in Asian countries.
The 1-year prevalence rate of PM was 14.1 % in the
present study. Previous epidemiological studies have
Table 1 Sociodemographic characteristics of survey participants; the total Korean population; and cases identified as having migraine,
probable migraine, and insomnia
Survey participants Total population P-value Migraine Probable migraine Insomnia
N (%) N (%) N, % (95 % CI) N, % (95 % CI) N, % (95 % CI)
Gender
Men 1345 (49.3) 17,584,365 (50.6) 0.854a 36, 2.7 (1.8–3.5) 136, 10.1 (8.5–11.8) 33, 2.5 (1.6–3.3)
Women 1350 (50.7) 17,198,350 (49.4) 107, 7.9 (6.5–9.4) 243, 17.9 (15.8–19.9) 83, 4.7 (3.5–5.8)
Age
19–29 542 (20.5) 7,717,947 (22.2) 0.917a 25, 4.5 (2.7–6.2) 69, 12.6 (9.8–15.4) 14, 2.6 (1.2–3.9)
30–39 604 (21.9) 8,349,487 (24.0) 42, 7.0 (4.9–9.1) 102, 16.8 (13.7–19.8) 19, 3.1 (1.7–4.5)
40–49 611 (23.1) 8,613,110 (24.8) 39, 6.5 (4.5–8.4) 102, 16.8 (13.9–19.8) 21, 3.4 (2.0–4.9)
50–59 529 (18.9) 6,167,505 (17.7) 22, 4.1 (2.4–5.9) 62, 11.6 (8.8–14.4) 23, 4.3 (2.6–6.1)
60–69 409 (15.6) 3,934,666 (11.3) 15, 3.9 (2.0–5.7) 44, 11.2 (8.1–14.2) 19, 4.6 (2.6–6.7)
Size of residential area
Large city 1248 (46.3) 16,776,771 (48.2) 0.921a 76, 6.1 (4.8–7.5) 180, 14.4 (12.4–16.3) 47, 3.8 (2.7–4.8)
Medium-to-small city 1186 (44.0) 15,164,345 (43.6) 48, 4.0 (2.9–5.2) 174, 14.7 (12.7–16.7) 41, 3.8 (2.4–4.5)
Rural area 261 (9.7) 2,841,599 (8.2) 19, 7.4 (4.2–10.6) 25, 9.7 (6.1–13.3) 8, 3.1 (1.0–5.2)
Education level
Middle school or less 393 (14.9) 6,608,716 (19.0) 0.752a 22, 5.5 (4.2–7.7) 44, 11.5 (8.4–14.7) 23, 5.9 (3.5–8.2)
High school 1208 (44.5) 15,234,829 (43.8) 60, 5.0 (3.8–6.3) 178, 14.7 (12.7–16.7) 40, 3.3 (2.3–4.3)
College or more 1068 (39.6) 12,939,170 (37.2) 60, 5.6 (4.3–7.0) 155, 14.4 (12.3–16.5) 32, 3.0 (2.0–4.0)
Not responded 26 (1.0) 1, 3.8 (0.0–11.8) 2, 7.7 (0.0–18.7) 1, 3.8 (0.0–11.8)
Total 2695 (100.0) 34,782,715 (100.0) 143, 5.3 (4.5–6.2) 379, 14.1 (12.7–15.4) 96, 3.6 (2.9–4.3)
CI Confidence Interval
aComparison of gender, age group, size of residential area, and educational level distributions between the sample in the present study and the total population
of Korea
Fig. 2 Distribution of insomnia severity in subjects with migraine
and probable migraine
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reported 1-year prevalence rates of PM ranging from 4.3
to 14.6 %. Thus, the prevalence rate of PM in the
present study was similar to those in the previous
studies [18, 20, 33–36].
The prevalence of insomnia (≥15.5 ISI score) in the
present study was 3.6 %. Insomnia prevalence has been
previously reported, ranging from 15.3 to 22.8 % in
Asian countries including Korea [37–39]. These findings
are inconsistent with the present study. This may reflect
different insomnia diagnostic criteria. Most previous
population-based studies about insomnia probed insom-
nia symptoms by asking whether subjects had difficult
falling asleep, staying asleep and waking too early in the
morning. A previous population-based study reported
prevalence of insomnia symptoms at least three nights
per week was 17.0 %, but insomnia disorder prevalence
based on Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV criteria was 5.0 % in this study [39].
Although the prevalence rate of insomnia was not
significantly different between subjects with migraine
and PM, the ISI score was significantly different between
the two groups in the present study. The difference was
associated with the higher prevalence of subthreshold
insomnia (8 ≤ ISI score ≤ 14) among subjects with
migraine compared to those with PM. The prevalence
rate of insomnia in subjects with migraine and PM was
higher compared to non-headache controls in the
present study. The finding agrees with findings in
previous studies concerning the association between
headache and insomnia [3]. Cross-sectional studies
showed that headache or migraine had increased ORs
compared to non-headache controls and longitudinal
studies showed bidirectional comorbidity of two condi-
tions: subjects with insomnia showed an increased risk for
headache at 11-year follow up and vice versa [10, 40].
A few studies have addressed the relationship be-
tween PM and insomnia among children. Children
with adult-like migraine had a higher prevalence of
sleep disorders compared to non-headache controls
(disorders of initiating and maintaining sleep;
migraine 37.1 % vs controls 9.2 %, disorders of
arousals; migraine 59.3 % vs controls 10.2 %) [41].
Sleep disorders in infancy could be good predictors
for the development of headache [42].
Table 2 The difference of demographic and clinical variables in subjects with migraine and PM according to insomnia status
Migraine PM
Insomnia (+), N = 13 Insomnia (−), N = 130 p Insomnia, N = 31 Insomnia, N = 348 p
Age, years 43.3 ± 16.3 41.0 ± 12.0 0.653a 45.0 ± 13.2 41.6 ± 12.5 0.151
Female, n (%) 10 (76.9 %) 97 (74.6 %) 0.855 21 (67.7 %) 222 (63.8 %) 0.702
Size of residential area 0.857 0.382
Large city, n (%) 7 (53.8 %) 69 (53.1 %) 14 (45.2 %) 166 (47.7 %)
Medium-to-small city, n (%) 5 (38.5 %) 43 (33.1 %) 13 (41.9 %) 161 (46.3 %)
Rural city, n (%) 1 (7.7 %) 18 (13.8 %) 4 (12.9 %) 21 (6.0 %)
Education level 0.081 0.886
Middle school or less, n (%) 6 (46.2 %) 16 (12.3 %) 3 (9.7 %) 4 (11.8 %)
High school, n (%) 3 (23.1 %) 57 (43.8 %) 16 (51.6 %) 162 (46.6 %)
College or more, n (%) 4 (30.8) 56 (43.1 %) 12 (38.7 %) 143 (41.1 %)
No answer, n (%) 0 (0.0 %) 1 (0.8 %) 0 (0.0 %) 2 (0.6 %)
GAS score 6.4 ± 2.1 3.3 ± 2.3 <0.001a 6.6 ± 1.8 2.4 ± 2.1 <0.001
PHQ-9 score 12.3 ± 6.4 4.0 ± 4.2 <0.001a 12.3 ± 6.7 2.8 ± 3.1 <0.001
PM Probable migraine, GAS Goldberg Anxiety Scale, PHQ-9 The Patient Health Questionnaire-9, SD Standard deviation
Values are expressed as mean ± SD, aMann-Whitney U test
Table 3 Headache frequency, headache pain intensity (VAS score), and Headache Impact Test-6 score in subjects with migraine or
PM according to insomnia status
Migraine PM
Insomnia (+), N = 13 Insomnia (−), N = 130 p Insomnia (+), N = 31 Insomnia (−), N = 348 p
Median (25–75 %) Median (25–75 %) Median (25–75 %) Median (25–75 %)
Headache frequencya (per 1 month) 4.0 (2.0–11.0) 1.0 (0.3–4.0) 0.004 2.0 (0.4–4.0) 1.0 (0.3–2.0) 0.004
VAS score for headache intensitya 7.0 (5.5–8.5) 6.0 (5.0–7.0) 0.076 6.0 (5.0–7.0) 5.0 (4.0–6.0) <0.001
HIT-6 scorea 65.0 (59.5–71.5) 52.0 (47.0–60.0) <0.001 54.0 (48.0–62.0) 45.5 (42.0–52.0) <0.001
PM Probable migraine, VAS Visual Analogue Scale, HIT-6 Headache Impact Test-6
aMann-Whitney U test
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In the present study demonstrated that depression
(PHQ-9 score), anxiety (GAD-7 score), headache
frequency and headache intensity (VAS score) were
independently associated with insomnia (ISI score)
among individuals with PM (Table 4). This finding
was similar to findings in the previous studies among
migraineurs. A study including 78 migraineurs and
208 healthy controls revealed that sleep quality and
headache frequency was significantly associated after
adjusting anxiety and depression [43]. Another study
demonstrated that migraineurs had more sleep prob-
lems than healthy controls even after adjusting life-
time anxiety and depression [44].
In the present study, headache frequency and HIT-6
score were higher in migraine and PM subjects with
insomnia than in those without insomnia. Since a high
headache frequency is one risk factor for chronification
of headaches, our finding suggests that insomnia may be
associated with the chronification of migraine and PM.
We also noted that insomnia was associated with a
higher HIT-6 score in subjects with migraine and PM.
This finding may imply an increased burden of migraine
and PM with the presence of insomnia [45]. Physicians
should evaluate accompanying insomnia in subjects with
migraine and PM. Careful investigation of the main
causes of insomnia including psychiatric co-morbidity is
also necessary.
This study has some limitations. First, although the
questionnaire in this study was validated for migraine,
it was not specifically validated for PM. However, the
questionnaire itself was based on ICHD-2 and PM
was classified based on the ICHD-2 diagnostic cri-
teria. Second, although this study is population-based
and had low sampling error, its statistical power was
limited in terms of examining the subgroups. In other
words, some results might not have reached statistical
significance in subgroup analysis because of the limited
sample size.
Despite these limitations, our study has several
strengths. First, our study was based on clustered ran-
dom sampling proportional to the Korean population
distribution with low sampling error. This condition
allowed us to accurately investigate the prevalence of
insomnia, migraine, and PM among the Korean adult
population. Second, this study explored the relation be-
tween PM and insomnia. This relation has been rarely
studied. Third, we investigated both anxiety and depres-
sion, which are common comorbidities among subjects
with insomnia and migraine, and assessed the effect of
anxiety and depression in the association of insomnia
with migraine and PM. Balancing the limitations and
strengths, we believe that the present study accurately
describes the association between insomnia and PM in
comparison with migraine.
Conclusions
The prevalence rate of insomnia in individuals with PM
is not significantly different compared to those with mi-
graine. Insomnia aggravates headache symptoms among
individuals with PM as well as among individuals with
migraine.
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